Company Filing History:
2 out of 5 
2 out of 2 Years Active: 2021-2022
Title: Shuang Pei: Innovator in Bispecific Antibody Development
Introduction
Shuang Pei is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases.
Latest Patents
Shuang Pei's latest patents include the development of an anti-EGFR and anti-CD3 bispecific antibody. This invention provides a bispecific antibody that can specifically bind to the epidermal growth factor receptor (EGFR) on tumor cell surfaces and the CD3 molecule on immune cell surfaces. The single-chain antibody (ScFv) of the anti-CD3 antibody is strategically located at the C terminal of the constant region of the anti-EGFR antibody. The patent also details a preparation method for the bispecific antibody and its clinical applications. This antibody has high affinity and is intended for treating tumor diseases associated with high or abnormal expression of EGFR, as well as other diseases linked to EGFR overexpression. Another significant patent is for an anti-PD-1 monoclonal antibody and its obtaining method. This invention provides human monoclonal antibodies that specifically bind to PD-1 with high affinity, inhibiting the binding of PD-1 to its ligand PD-L1. These antibodies are applicable in treating tumors, inflammation, and autoimmune diseases.
Career Highlights
Shuang Pei has worked with notable companies in the biotechnology sector, including Beijing Dongfang Biotech Co., Ltd. and Beijing Jingyitaixiang Technology Development Co. Ltd. His expertise in antibody development has positioned him as a key player in the industry.
Collaborations
Shuang Pei has collaborated with several professionals in his field, including Yi Bai and Yanlu Zan, who is a woman. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Shuang Pei's contributions to the field of biotechnology, particularly in bispecific antibodies, highlight his role as an innovator. His patents reflect a commitment to developing effective treatments for serious health conditions.